Andy Molnar, CEO of the Digital Therapeutics Alliance, has been appointed as an industry representative for the FDA's Digital Health Advisory Committee (DHAC). The DHAC was established to ensure the safe and effective regulation of various digital health technologies, including AI, machine learning, virtual reality, cybersecurity, patient-generated health data, and wearable technologies. Molnar's role will encompass real-world data and evidence, digital diagnostics, decentralized clinical trial technologies, and augmented reality and virtual reality, focusing on both technical and clinical aspects.
Molnar expressed his commitment to advocating for innovation and patient access to evidence-based digital therapeutics. In a LinkedIn post, he stated his enthusiasm for collaborating with colleagues to integrate digital therapeutic solutions into the healthcare system, aiming to improve patient outcomes. The committee advises the FDA commissioner on issues related to digital health tech, as well as policies and regulations governing these technologies.
In other industry news, Arrive AI announced the appointment of John Gallina, former CFO of Elevance Health, and Jim Brainard, former mayor of Carmel, California, to its team. Arrive AI specializes in automated delivery systems for healthcare organizations. Gallina will join the company's board and chair the Audit Committee, while Brainard will focus on municipal partner development. Additionally, CareAbout Health has appointed Masoud Nourmohammadi as its new chief technology officer. Nourmohammadi, who has held senior technology roles at Health Catalyst, Strive Health, and Herself Health, will lead the development of CareAbout Health's technology and analytics initiatives.
Click here to read the original news story.